Studies concerning the development of radiopharmaceuticals based on the Tc (I) carbonyl core are considered from the coordination-chemical viewpoint. The coordination behavior of …
NC Okoye, JE Baumeister, F Najafi Khosroshahi… - Radiochimica …, 2019 - degruyter.com
Diagnostic and therapeutic nuclear medicine relies heavily on radiometal nuclides. The most widely used and well-known radionuclide is technetium-99m (99mTc), which has …
Targeted radionuclide therapy (TRNT) is an ever-expanding field of nuclear medicine that provides a personalised approach to cancer treatment while limiting toxicity to normal …
Technetium (I) 2+ 1 tricarbonyl complexes with a combination of N, N-bidentate ligands (2, 2′-bipyridine, bipy; 1, 10-phenanthroline, phen) and ethyl isocyanoacetate were prepared …
Re (I) tricarbonyl complexes, with coordinated β-diketones, are the center of attention as they form part of a library of promising cancer therapeutic and diagnostic agents. In this …
VL Gantsho, M Dotou, M Jakubaszek, B Goud… - Dalton …, 2020 - pubs.rsc.org
Rhenium (I) di-and tri-carbonyl complexes of the form fac-[Re (CO) 3 (L, L′-Bid) X] and [Re (CO) 2 (L, L′-Bid) X2], where X= aqua (H2O), methanol (CH3OH), triphenylphosphine …
A Shegani, M Ischyropoulou, I Roupa, C Kiritsis… - Bioorganic & Medicinal …, 2021 - Elsevier
Abstract A series of “2+ 1” mixed ligand tricarbonyl complexes of the general formula fac- [Re/99m Tc/186 Re (CO) 3 (DDTC)(L)] containing diethyldithiocarbamate (DDTC) as a …
The synthesis and characterization of the dicarbonyl mixed ligand cis-[Re (CO) 2 (quin)(cisc)(PPh3)] complex, 4, where quin is the deprotonated quinaldic acid, cisc is …
Abstract fac-[Re (OH 2) 3 (CO) 3]+ reacts with acetylacetone (AcacH) at room temperature to yield fac-[Re (Acac)(CO) 3 (OH 2)](1) under aqueous conditions 1 was isolated and reacted …